A detailed history of Entry Point Capital, LLC transactions in Penumbra Inc stock. As of the latest transaction made, Entry Point Capital, LLC holds 2,215 shares of PEN stock, worth $532,397. This represents 0.25% of its overall portfolio holdings.

Number of Shares
2,215
Previous 877 152.57%
Holding current value
$532,397
Previous $158 Million 99.73%
% of portfolio
0.25%
Previous 0.23%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$163.64 - $210.12 $218,950 - $281,140
1,338 Added 152.57%
2,215 $430,000
Q2 2024

Aug 13, 2024

BUY
$172.27 - $223.95 $62,017 - $80,622
360 Added 69.63%
877 $158 Million
Q1 2024

May 14, 2024

BUY
$220.09 - $273.15 $96,619 - $119,912
439 Added 562.82%
517 $115 Million
Q4 2023

Feb 14, 2024

BUY
$181.44 - $260.22 $14,152 - $20,297
78 New
78 $19.6 Million

Others Institutions Holding PEN

About Penumbra Inc


  • Ticker PEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 37,888,400
  • Market Cap $9.11B
  • Description
  • Penumbra, Inc. designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers aspiration based thrombectomy systems and accessory devices, including revascularization device for mechanical thrombectomy, such as Penumbra System under the Penumbra RED, JET, ACE, 3D Revascularization Device...
More about PEN
Track This Portfolio

Track Entry Point Capital, LLC Portfolio

Follow Entry Point Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Entry Point Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Entry Point Capital, LLC with notifications on news.